| Financial Year |
March 31 2023 |
| Monetary Funds |
80,460,090.96 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
150,893.53 |
| Accounts Receivable |
324,082,361.75 |
| Advances to Suppliers |
24,000,808.82 |
| Other Receivables |
13,037,906.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
256,547,539.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
26,324,901.25 |
| Total Current Assets |
826,441,752.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
677,495,191.91 |
| Under-construction Projects |
25,954,364.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
54,271,688.84 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,878,224.59 |
| Deferred Income Tax Assets |
37,368,924.11 |
| Other Non-Current Assets |
6,746,883.57 |
| Sub-Total of Non-Current Assets |
874,958,935.42 |
| Total Assets |
1,701,400,688.26 |
| Short-Term Loans |
382,511,867.64 |
| Trading Financial liabilities |
-- |
| Notes Payable |
82,238,995.76 |
| Accounts Payable |
341,365,739.46 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,943,514.65 |
| Taxes Payable |
6,137,772.15 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
22,298,795.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
1,009,813.71 |
| Sub-Total of Current Liabilities |
856,582,592.39 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
7,729,468.67 |
| Deferred Income Tax Liabilities |
593,889.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
51,271,645.49 |
| Total Liabilities |
907,854,237.88 |
| Paid-In Capital(Or Share Stock) |
115,022,000.00 |
| Capital Surplus |
740,047,247.92 |
| Surplus Reserve |
26,603,251.15 |
| LESS:Treasury Stock |
15,270,000.00 |
| Undistributed Profits |
-72,856,048.69 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
793,546,450.38 |
| Owner's Equity（Stockholder's Equity） |
793,546,450.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,701,400,688.26 |
